Zerbini C, Weinberg D S, Hollister K A, Perez-Atayde A R
Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
Am J Pathol. 1992 May;140(5):1111-9.
Hereditary tyrosinemia (HT) is an autosomal recessive disorder of tyrosine metabolism that results in cirrhosis and hepatocellular carcinoma early in life, and that may be a useful model of early malignant transformation. This is the first report of DNA ploidy in this disease. The authors studied formalin-fixed liver tissue in three cases (two chronic and one acute) of HT for the presence of DNA aneuploidy by flow cytometric (FCM) analysis and image analysis (IA). In the chronic cases, the authors found DNA aneuploidy by FCM in 2/20 cirrhotic nodules in one case and 1/21 tissue sections in the other. Questionable minor aneuploid peaks were detected by FCM in 2/20 and 2/21 sections in these two cases, respectively. Static DNA measurements by IA were performed on those sections having abnormal histograms as well as in some sections having diploid DNA distribution. By this method, the authors confirmed the results of FCM studies and found additional small aneuploid nodules not detected by FCM, frequently associated with various forms of hepatocellular dysplasia as well as steatosis. In one case of acute HT (autopsy), no definite aneuploid peaks were present in five blocks. By immunohistochemical analysis, the authors found frequent positive staining for alpha-fetoprotein (AFP) in the cirrhotic nodules of the two chronic cases as well as in the steatotic regenerative nodules of the acute case. The expression of AFP may represent disturbed regeneration and maturation of liver cells in this disease. This study shows that DNA ploidy may be a useful marker for early malignant transformation in HT and supports the preneoplastic nature of the hepatocellular dysplasia in this disease.
遗传性酪氨酸血症(HT)是一种常染色体隐性酪氨酸代谢紊乱疾病,可在生命早期导致肝硬化和肝细胞癌,可能是早期恶性转化的有用模型。这是关于该疾病DNA倍体的首次报告。作者通过流式细胞术(FCM)分析和图像分析(IA),研究了3例HT患者(2例慢性和1例急性)经福尔马林固定的肝组织中DNA非整倍体的情况。在慢性病例中,作者通过FCM在1例患者的20个肝硬化结节中的2个以及另一例患者的21个组织切片中的1个发现了DNA非整倍体。在这两个病例中,分别在20个切片中的2个和21个切片中的2个通过FCM检测到可疑的微小非整倍体峰。对那些直方图异常的切片以及一些DNA呈二倍体分布的切片进行了IA静态DNA测量。通过这种方法,作者证实了FCM研究的结果,并发现了FCM未检测到的额外小非整倍体结节,这些结节常与各种形式的肝细胞发育异常以及脂肪变性相关。在1例急性HT(尸检)病例中,5个组织块中未出现明确的非整倍体峰。通过免疫组织化学分析,作者发现2例慢性病例的肝硬化结节以及急性病例的脂肪变性再生结节中,甲胎蛋白(AFP)染色经常呈阳性。AFP的表达可能代表了该疾病中肝细胞再生和成熟的紊乱。本研究表明,DNA倍体可能是HT早期恶性转化的有用标志物,并支持了该疾病中肝细胞发育异常的肿瘤前性质。